Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced the Company’s inaugural Environmental, Social, and Governance (ESG) report including a baseline of...
Uli Broedl, VP of Medical and Regulatory Affairs at BI Canada with Matt Bird at Converge2Xcelerate Conference (Boston, MA)